Description
Relugolix (RVT-601) is an orally available, non-peptide gonadotropin-releasing hormone (GnRH or luteinizing hormone-releasing hormone (LHRH)) antagonist, with potential antineoplastic activity.
Molecular Formula
C29H27F2N7O5S
Smiles
CONC(=O)NC1CCC(CC1)-C1sC2N(CC3C(F)CCCC3F)C(=O)N(-C3CCC(OC)NN3)C(=O)C2C1CN(C)C
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
DMSO: 50 mg/mL (80.18 mM), Sonication is recommended.
Relative Density
1.442 (Predicted)